Concentrix (NASDAQ:CNXC) Updates Q3 2025 Earnings Guidance

Concentrix (NASDAQ:CNXC - Get Free Report) updated its third quarter 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 2.800-2.910 for the period, compared to the consensus earnings per share estimate of 2.900. The company issued revenue guidance of $2.4 billion-$2.5 billion, compared to the consensus revenue estimate of $2.4 billion. Concentrix also updated its FY 2025 guidance to 11.530-11.760 EPS.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on CNXC. Bank of America dropped their price target on shares of Concentrix from $65.00 to $61.00 and set a "neutral" rating for the company in a research note on Friday. Barrington Research reissued an "outperform" rating and set a $54.00 price target on shares of Concentrix in a research note on Tuesday, June 24th. Wall Street Zen downgraded shares of Concentrix from a "buy" rating to a "hold" rating in a research note on Saturday, June 21st. Finally, Robert W. Baird boosted their price target on shares of Concentrix from $62.00 to $72.00 and gave the stock an "outperform" rating in a research note on Thursday. Two analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Concentrix has an average rating of "Moderate Buy" and a consensus target price of $66.75.

Concentrix Trading Down 6.2%

NASDAQ:CNXC traded down $3.42 during trading hours on Friday, hitting $51.71. The stock had a trading volume of 2,359,685 shares, compared to its average volume of 734,237. Concentrix has a one year low of $36.28 and a one year high of $77.00. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.65 and a current ratio of 1.61. The company has a market cap of $3.30 billion, a price-to-earnings ratio of 14.21, a P/E/G ratio of 0.67 and a beta of 0.56. The business's 50 day moving average is $53.86 and its 200-day moving average is $49.54.

Concentrix (NASDAQ:CNXC - Get Free Report) last issued its earnings results on Thursday, June 26th. The company reported $2.70 EPS for the quarter, missing the consensus estimate of $2.76 by ($0.06). Concentrix had a net margin of 2.54% and a return on equity of 16.31%. The firm had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.38 billion. During the same period in the previous year, the company posted $2.69 EPS. The firm's revenue for the quarter was up 1.5% on a year-over-year basis. Sell-side analysts anticipate that Concentrix will post 10.11 EPS for the current fiscal year.

Concentrix Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, August 5th. Shareholders of record on Friday, July 25th will be paid a $0.3328 dividend. This represents a $1.33 annualized dividend and a yield of 2.57%. The ex-dividend date of this dividend is Friday, July 25th. Concentrix's payout ratio is presently 33.33%.

Insider Buying and Selling at Concentrix

In other news, EVP Cormac J. Twomey sold 500 shares of the stock in a transaction on Monday, March 31st. The shares were sold at an average price of $55.31, for a total transaction of $27,655.00. Following the completion of the sale, the executive vice president now owns 39,130 shares of the company's stock, valued at $2,164,280.30. This represents a 1.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Christopher A. Caldwell acquired 1,000 shares of the stock in a transaction dated Monday, April 21st. The shares were bought at an average cost of $46.00 per share, with a total value of $46,000.00. Following the transaction, the chief executive officer now directly owns 303,362 shares of the company's stock, valued at $13,954,652. This represents a 0.33% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders sold 30,944 shares of company stock valued at $1,510,158. Corporate insiders own 3.20% of the company's stock.

Institutional Investors Weigh In On Concentrix

Large investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. increased its position in shares of Concentrix by 75.1% during the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company's stock worth $23,552,000 after acquiring an additional 181,546 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Concentrix by 17.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company's stock worth $8,152,000 after acquiring an additional 21,746 shares in the last quarter. Royal Bank of Canada increased its position in shares of Concentrix by 9.5% during the first quarter. Royal Bank of Canada now owns 47,501 shares of the company's stock worth $2,643,000 after acquiring an additional 4,133 shares in the last quarter. Focus Partners Wealth bought a new stake in shares of Concentrix during the first quarter worth $781,000. Finally, Geneos Wealth Management Inc. increased its position in shares of Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock worth $34,000 after acquiring an additional 522 shares in the last quarter. Institutional investors own 90.34% of the company's stock.

About Concentrix

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.